Restricted accessReview articleFirst published online 1992-07
A pilot study,review of the literature,and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer pain
Providing effective pain control without side effects is a major challenge in patients with advanced cancer. Oral analgesics may not be practical for a variety of reasons, and several alternatives for parenteral administration are available, including patient-controlled analgesia (PCA). This is a report of a pilot study of the effectiveness, dose requirements, side effects and practicality of continuous subcutaneous morphine infusion delivered by PCA in nine patients. A review of the literature of subcutaneous morphine infusions and guidelines for use are described. Continuous subcutaneous infusion of morphine via a PCA device appears to be a safe and effective method of pain control in patients with advanced cancer.
Walsh TDOral morphine in chronic cancer pain. Pain1990; 18: 1-11.
3.
Kerr IG, Sone M., Deangelis C., Iscoe N., MacKenzie R., Schueller T.Continuous narcotic infusion with PCA for chronic cancer pain in outpatients . Ann Intern Med1988; 108: 554-57.
4.
Bruera E., Brenneis C., Michaud M. et al. Use of subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer1988; 62: 407-11.
5.
Swanson G., Smith J., Bulich R., New P., Shiffman R.Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol1989 ; 7: 1903-1908.
6.
Glare P., Sheehan D., Smyth E., Walsh TDPilot survey of the side effects of morphine sulphate in advanced cancer. [in preparation].
7.
Walsh TD, Saunders CMOral morphine for relief of chronic pain from cancer. N Engl J Med1981; 305:1417.
8.
Portenoy RK, Moulin DE, Rogers A., Inturrisi CE, Foley KMIntravenous infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep1986; 70: 575-81.
9.
Glare P., Smyth E., Walsh TDContinuous intravenous morphine sulphate infusions for cancer pain. [in preparation].
10.
Bonica JJ, Ekstrom JLSystemic opioids for the management of cancer pain: an updated review. In: Benedetti C, Chapman CR, Giron G eds. Opioid analgesia (Advances in pain research and therapy, volume 14). New York: Raven Press, 1990:425-46.
11.
Logan M., Bourbonnais FFContinuous subcutaneous infusion of narcotics: an exploratory study of patient, family and nursing concerns. Hospice J1990 ; 6: 69-77.
12.
Russell Psb.Analgesia in terminal malignant disease. Br Med J1979; 1: 1561.
13.
Hutchinson H. , Leedham GD, Knight AMContinuous subcutaneous analgesics in domiciliary terminal care. Lancet1981; ii: 1279.
14.
Campbell CF, Mason JB, Weiler JMContinuous subcutaneous infusion of morphine for the pain of terminal malignancy . Ann Intern Med1983; 98: 51-52.
15.
Dickson RJ, Russell Psb.Continuous subcutaneous analgesics for terminal care at home. Lancet1982; i: 165.
16.
Miser AW, Davis DM, Hughes CS, Mulne AF, Miser JSContinuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child1983; 137: 383-85.
17.
Ventafridda V., Spoldi E., Carceni A., Tamburini M De Conno F. The importance of continuous subcutaneous morphine administration for cancer pain control. Pain Clinic1986; 1: 47-55.
18.
Coyle N., Mauskop A., Maggard J., Foley KMContinuous subcutaneous infusions of opiates in cancer patients with pain . Oncol Nurs Forum1986; 13: 53-57.
19.
Brenneis C. , Michaud M., Bruera E., MacDonald RNLocal toxicity during the subcutaneous infusion of narcotics (SCIN). Cancer Nurs1987; 10: 172-76.
20.
Benedetti C.Acute pain: a review of its effects and therapy with systemic opioids. In: Benedetti C, Chapman DR, Giron G eds. Opioid analgesia (Advances in pain research and therapy, volume 14). New York: Raven Press, 1990: 367-424.
21.
Citron ML, Johnston-Early A., Boyer M., Krasnow SH, Hood M., Cohen MHPatient-controlled analgesia for severe cancer pain. Arch Intern Med1986; 146: 734-36.
22.
Baumann TJ, Batenhorst RL, Graves DA, Foster TS, Bennett RLPatient-controlled analgesia in the terminally ill cancer patient. Drug Intell Clin Pharm1986; 20: 297-301.
23.
Keeri-Szanto M.Demand analgesia for the relief of pain problems in 'terminal' illness. Anesth Rev1976; 3: 19-21.
24.
Bruera E., Brenneis C., Michaud M., MacMillan K., Hanson J., MacDonald RNPatient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. J Natl Cancer Inst1988; 80: 1152-54.
25.
Drexel H., Dzien A., Spiegel RW et al. Treatment of severe cancer pain by low-dose continuous subcutaneous morphone. Pain1989; 36: 169-76.
26.
Rutter PC, Murphy F., Hadley Haf.Morphine: controlled trial of different methods of administration for post-operative pain relief. Br Med J1980; 1: 12-13.
